Complications of Lipostabil Endovena for treating localized fat deposits

Background Subcutaneous injection of Lipostabil Endovena (Nattermann & Cie, Koln, Germany) has been used to treat periorbital fat pads, as well as localized fat deposits in the abdomen, neck, arms, and thighs. Objecive The goal of this article was to identify complications resulting from the use of Lipostabil Endovena for treating fat deposits. Methods A prospective study was conducted to identify complications associated with injection lipolysis with Lipostabil Endovena. Patients were surveyed at 48 hours, 2 weeks, and 2 months after the last injection session. Results The 739 patients surveyed received a total of 2852 vials injected. No general symptoms, such as fever, dizziness, gastrointestinal disturbances, or visual disturbances occurred, although local symptoms, including edema, hematoma, pain, and nodules, were reported. Conclusions The lack of any reported general complications after injection lipolysis with Lipostabil Endovena is encouraging. However, larger studies are needed to confirm that the use of Lipostabil Endovena is safe.